Effects of MTRPs Therapy in Migraine.

NCT05646160 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-03-02

No results posted yet for this study

Summary

Case series, repeated-measures design, pilot study.

Adult, female, migraine patients underwent seven Ischemic Compression Myofascial Trigger Points (IC-MTrPs) therapy sessions.

The aim of the study is to investigate whether therapy of the shoulder girdle and neck muscles by deactivating MTrPs causes modification of biomechanical and biochemical variables in the blood and reduces headache in people with migraine, improving their quality of life by improving their health.

People qualified for the study were divided into 3 groups according to the type of migraine:

1. CM group - patients with chronic migraine
2. EMa group - patients with paroxysmal migraine with aura
3. EMb group - patients with paroxysmal migraine without an aura.

All patients underwent 7 interventions in the area of the muscles of the shoulder girdle and neck (by deactivating trigger points) performed every 2 or 3 days. They did not take any headache medications during the treatment period. However, during a migraine attack, they could undergo treatments and research measurements. Biomechanical measurements of the cervical spine, shoulder girdle muscles and blood chemistry were performed before, during and after the patients' therapy.

All treatments were performed on the following muscles:

* m. trapesius pars descendent (trapezius upper),
* m. sternocleidomastoideus (sternocleidomastoid),
* m. temporalis (temporal),
* m. legator scapulae (levator scapula),
* m. supraspinatus (supraspinatus),
* m. suboccipitales (suboccipital).

Conditions

  • Migraine
  • Pain, Shoulder
  • Trapezius Muscle Strain Left
  • Trapezius Muscle Strain Right
  • Muscle Pain
  • Trigger Point Pain, Myofascial
  • Cervical Pain

Interventions

OTHER

Ischemic Compression of Myofascial Trigger Points (IC-MTRPs)

IC-MTrPs intervention was made first on the right side and then on the left side and this order was the same in each patient. Before starting the therapeutic procedure, the MTrPs localizations were identified by palpation and pinch pressure in patients lying back on the couch. During the procedure, a qualified physiotherapist sat behind the subject's head. The pressure was sustained for about 5 seconds with a 2-3 seconds pause. In each subject, the intervention lasted 15 minutes on the same measurement day in the morning. The subjects underwent cycle of seven IC-MTrPs therapeutic sessions, with 3 days brakes between each session, that lasted in total about a 3-weeks (25 days).

Sponsors & Collaborators

  • Wroclaw University of Health and Sport Sciences

    collaborator OTHER
  • Józef Piłsudski University of Physical Education

    lead OTHER

Principal Investigators

  • Aneta Łuć · Regional Research and Development Center in Biała Podlaska

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-15
Primary Completion
2023-03-01
Completion
2023-03-02

Countries

  • Poland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05646160 on ClinicalTrials.gov